Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Clinicopathological analysis for recurrence of stage Ib gastric cancer (according to the second English edition of the Japanese classification of gastric carcinoma).

Yokoyama T, Kamada K, Tsurui Y, Kashizuka H, Okano E, Ogawa S, Obara S, Tatsumi M.

Gastric Cancer. 2011 Oct;14(4):372-7. doi: 10.1007/s10120-011-0051-3. Epub 2011 May 18.

PMID:
21590318
2.

A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury.

Akahori T, Sho M, Kashizuka H, Nomi T, Kanehiro H, Nakajima Y.

Transplant Proc. 2006 Dec;38(10):3366-8.

PMID:
17175273
3.

A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model.

Suzaki Y, Hamada K, Sho M, Ito T, Miyamoto K, Akashi S, Kashizuka H, Ikeda N, Nakajima Y, Iwase M, Homma I, Kobzik L, Kimura H.

J Allergy Clin Immunol. 2005 Dec;116(6):1220-7. Epub 2005 Nov 8.

PMID:
16337449
4.

Function of the vascular endothelial growth factor receptors Flt-1 and Flk-1/KDR in the alloimmune response in vivo.

Sho M, Akashi S, Kanehiro H, Hamada K, Kashizuka H, Ikeda N, Nomi T, Kuzumoto Y, Tsurui Y, Yoshiji H, Wu Y, Hicklin DJ, Briscoe DM, Nakajima Y.

Transplantation. 2005 Sep 27;80(6):717-22.

PMID:
16210956
5.

Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice.

Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kubo A, Kanehiro H, Nakajima Y.

Hepatology. 2005 Sep;42(3):608-17.

PMID:
16108069
6.

A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.

Akashi S, Sho M, Kashizuka H, Hamada K, Ikeda N, Kuzumoto Y, Tsurui Y, Nomi T, Mizuno T, Kanehiro H, Hisanaga M, Ko S, Nakajima Y.

Transplantation. 2005 Aug 15;80(3):378-84.

PMID:
16082334
7.

Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury.

Tsurui Y, Sho M, Kuzumoto Y, Hamada K, Akashi S, Kashizuka H, Ikeda N, Nomi T, Mizuno T, Kanehiro H, Nakajima Y.

Transplantation. 2005 May 15;79(9):1110-5.

PMID:
15880052
8.

Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection.

Kashizuka H, Sho M, Nomi T, Ikeda N, Kuzumoto Y, Akashi S, Tsurui Y, Mizuno T, Kanehiro H, Yagita H, Nakajima Y, Sayegh MH.

Transplantation. 2005 May 15;79(9):1045-50.

PMID:
15880041
9.

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer.

Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, Mizuno T, Yoriki R, Kashizuka H, Yane K, Tsushima F, Otsuki N, Yagita H, Azuma M, Nakajima Y.

Clin Cancer Res. 2005 Apr 15;11(8):2947-53.

10.

Role of EP4 prostaglandin E2 receptor in the ischemic liver.

Kuzumoto Y, Sho M, Ikeda N, Mizuno T, Hamada K, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kanehiro H, Nakajima Y.

Transplant Proc. 2005 Jan-Feb;37(1):422-4.

PMID:
15808664

Supplemental Content

Loading ...
Support Center